Motif registers $40.25 million of stock for initial public ADS sale

SunTrust Robinson helps fund clinical trials, research, development

By Devika Patel

Knoxville, Tenn., July 13 – Motif Bio plc will price its initial public offering of American Depositary Shares with a 30-day greenshoe, according to a Form F-1 filed Wednesday with the Securities and Exchange Commission. The company has registered up to $40.25 million of underlying ordinary stock.

SunTrust Robinson Humphrey is the bookrunner.

Proceeds will be used for clinical trials, working capital, general and administrative expenses, research and development and other general corporate purposes.

The biopharmaceutical company is based in London. The company intends to list the ADS on the Nasdaq under the symbol “MTFB.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.